2668 related articles for article (PubMed ID: 26306578)
41. Effect of alcohol on blood pressure.
Tasnim S; Tang C; Musini VM; Wright JM
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012787. PubMed ID: 32609894
[TBL] [Abstract][Full Text] [Related]
42. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
43. Clinical efficacy of carvedilol in severe hypertension.
Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
[TBL] [Abstract][Full Text] [Related]
44. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
46. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
47. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
48. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
49. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
Law MR; Wald NJ; Morris JK; Jordan RE
BMJ; 2003 Jun; 326(7404):1427. PubMed ID: 12829555
[TBL] [Abstract][Full Text] [Related]
50. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
51. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
52. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PH; Souza ER
Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
[TBL] [Abstract][Full Text] [Related]
53. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
54. Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review.
Musini VM; Fortin PM; Bassett K; Wright JM
J Hum Hypertens; 2009 Aug; 23(8):495-502. PubMed ID: 19158826
[TBL] [Abstract][Full Text] [Related]
55. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
56. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
Ho MJ; Li EC; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007435. PubMed ID: 26935713
[TBL] [Abstract][Full Text] [Related]
57. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
58. Oral beta-blockers for mild to moderate hypertension during pregnancy.
Magee LA; Duley L
Cochrane Database Syst Rev; 2000; 2003(4):CD002863. PubMed ID: 11034777
[TBL] [Abstract][Full Text] [Related]
59. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PHF; Souza ERM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008652. PubMed ID: 28406263
[TBL] [Abstract][Full Text] [Related]
60. Blood pressure lowering efficacy of loop diuretics for primary hypertension.
Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
Cochrane Database Syst Rev; 2012 Aug; (8):CD003825. PubMed ID: 22895937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
